Additionally, daidzein has also been shown to enhance the anticancer effect of topotecan and reverse BCRP-mediated drug resistance in breast cancer (Guo et al., 2019), and it inhibits lung metastasis in mice induced by B16F-10 melanoma cells (Menon et al., 1998). Here, ABCG2 is linked to breast cancer.